-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-09-16
Cy5 NHS ester(Et) is an amine-reactive fluorescent reagent for covalently labeling proteins, peptides, and other biomolecules for immunofluorescence, flow cytometry, and fluorescence microscopy. It is suited to freshly prepared aqueous or DMSO workflows, but not to ethanol-based protocols or long-term storage of working solutions.
-
Hypoxia and Immunometabolism in Tumors
2026-09-16
This 2025 review explains how oxygen deprivation and nutrient competition jointly reprogram tumor and immune-cell metabolism within the tumor microenvironment. Its central contribution is a systems-level framework linking HIF signaling, glucose dependence, immune dysfunction, and therapeutic opportunities while highlighting the limits of translating metabolic findings into clinical interventions.
-
ATRA Reverses Cisplatin-Linked PARP Resistance in EOC
2026-09-15
The reference study shows that cisplatin exposure can create a PARP inhibitor-resistant state in epithelial ovarian cancer through coordinated changes in NAD+ metabolism, aldehyde dehydrogenase activity, and DNA-damage signaling. It further identifies all-trans retinoic acid as a clinically relevant strategy for reducing this state and improving the activity of niraparib maintenance therapy in preclinical models.
-
BAPTA and the Calcium-Controlled Toxicity Switch
2026-09-15
BAPTA is more than a calcium chelator: used as a causal perturbation tool, it can help translational researchers distinguish calcium-driven apoptosis from downstream correlation. This article interprets recent nanoplastic–cadmium findings, outlines a study-aligned workflow, and explains how BAPTA supports stronger environmental toxicology and cell signaling studies.
-
VX-661: F508del CFTR Corrector Guide
2026-09-14
VX-661 is a small-molecule F508del CFTR corrector that supports mutant-protein folding, trafficking, and cell-surface expression in cystic fibrosis research. Product and peer-reviewed evidence support its use as a corrector-focused tool that is mechanistically distinct from the potentiator VX-770.
-
RESTRICT-seq Maps Epigenetic Dependencies in SCC Resistance
2026-09-14
The reference preprint introduces RESTRICT-seq, a time-gated CRISPR screening strategy designed to distinguish early drivers of squamous cell carcinoma resistance from dependencies that sustain the resistant state. Its identification of KAT6A as an epigenetic vulnerability provides a framework for studying resistance-associated cell-state regulation and prioritizing mechanistic follow-up experiments.
-
Shaped ABC Coil-Bottlebrush Terpolymer Self-Assembly
2026-09-13
This study examines how digitally shaped bottlebrush blocks and block sequence influence phase behavior in ABC coil-bottlebrush terpolymers. SAXS showed robust microphase separation but systematic suppression of double-gyroid formation and unexpectedly slow structural ordering, providing important design constraints for large-period network materials.
-
2X HyperFusion High-Fidelity Master Mix for CRISPR
2026-09-12
Discover how the 2X HyperFusion High-Fidelity Master Mix supports accurate PCR in CRISPR-enabled oncology research. This article connects a recent bufalin–CRISPR nanomedicine study to practical assay design, construct verification, and fidelity-driven workflow decisions.
-
FK866 (APO866): Turning NAD Depletion into Insight
2026-09-11
A mechanistic and translational framework for using FK866 (APO866) to study NAMPT dependence, NAD depletion, mitochondrial stress, and therapeutic vulnerability across hematologic cancer research, with a carefully bounded connection to PARP inhibitor resistance in ovarian cancer.
-
Dihydroartemisinin: From Mechanism to Translation
2026-09-11
Dihydroartemisinin is more than a familiar antimalarial scaffold. Its mTOR-linked effects on cell proliferation, antipsoriasis and anti-inflammatory research relevance, and defined formulation profile make it a useful translational benchmark. This article explains how to position the compound alongside emerging antiplasmodial strategies such as phebestin while keeping evidence, experimental design, and development maturity clearly separated.
-
Phenothiazines, ROS, and Macrophage Antibacterial Defense
2026-09-10
Qiu et al. report that phenothiazines strengthen macrophage control of intracellular bacteria by increasing reactive oxygen species, lysosomal activity, and autophagy. The study positions perphenazine as a host-directed antibacterial lead while showing that pharmacological disruption of ROS or autophagy reduces the protective phenotype.
-
mRNA-LNP Programming of CAR Macrophages
2026-09-10
Gu et al. develop a macrophage-targeted mRNA lipid nanoparticle system for intraperitoneal programming of chimeric antigen receptor macrophages and compare 36 CAR formats. The study identifies CD3ζ–TLR4 intracellular domains as a tailored design that reshapes the tumor microenvironment, expands TCF1+PD-1+ progenitor-exhausted CD8+ T cells, and improves responses to PD-1/L1 therapy.
-
PRDX5 Acetylation in Retinal Ischemia-Reperfusion
2026-09-09
The reference study identifies PRDX5 acetylation as a regulatory event that weakens antioxidant and anti-apoptotic protection during retinal ischemia-reperfusion injury. Using an acute high-intraocular-pressure mouse model and OGD/R-treated R28 cells, the authors connect PRDX5 abundance and acetylation status with oxidative stress, mitochondrial dysfunction, and neuronal apoptosis, providing a mechanistic framework for follow-up studies.
-
Coke Oven Emissions, Ferroptosis, and Allergic Asthma
2026-09-09
This study provides experimental evidence that coke oven emissions intensify house dust mite–induced allergic asthma in mice and identifies ferroptosis in airway epithelial cells as a mechanistic link. Its combined exposure, iron-chelation, and 3-MA intervention design connects environmental pollution with iron-dependent cell death and suggests a framework for studying pollutant-aggravated airway disease.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-09-08
Learn how to use a hypersensitive ECL workflow for immunoblotting detection of low-abundance proteins, from membrane preparation through exposure optimization. The approach combines low-background horseradish peroxidase chemiluminescence with practical assay controls, pathway-focused applications, and troubleshooting for nitrocellulose and PVDF membranes.